Ocular Manifestations of COVID-19
Progress in Retinal and Eye Research,
Journal Year:
2024,
Volume and Issue:
102, P. 101285 - 101285
Published: June 24, 2024
There
is
an
increasing
body
of
knowledge
regarding
how
COVID-19
may
be
associated
with
ocular
disease
varying
severity
and
duration.
This
article
discusses
the
literature
on
manifestations
COVID-19,
including
appraisal
current
evidence,
suggested
mechanisms
action,
comorbidities
risk
factors,
timing
from
initial
infection
to
diagnosis
clinical
red
flags.
The
primarily
comprises
case
reports
series
which
inevitably
lack
control
groups
evidence
support
causality.
However,
these
early
data
have
prompted
development
larger
population-based
laboratory
studies
that
are
emerging.
As
new
become
available,
a
better
true
effects
eye
will
possible.
While
pandemic
was
officially
declared
no
longer
"global
health
emergency"
by
World
Health
Organization
(WHO)
in
May
2023,
numbers
continue
rise.
Reinfection
different
variants
predicted
lead
growing
cumulative
burden
disease,
particularly
as
more
chronic,
multi-organ
sequelae
apparent
potentially
significant
implications.
postulated
due
three
main
mechanisms:
firstly,
there
dysregulated
immune
response
linked
inflammatory
disease;
secondly,
patients
greater
tendency
towards
hypercoagulable
state,
leading
prothrombotic
events;
thirdly,
severe
requiring
hospitalisation
immunosuppressed
administered
corticosteroids
or
such
diabetes
mellitus
at
increased
secondary
infections,
endophthalmitis
rhino-orbital-mucormycosis.
Reported
ophthalmic
associations
therefore,
include
range
conditions
conjunctivitis,
scleritis,
uveitis,
endogenous
endophthalmitis,
corneal
graft
rejection,
retinal
artery
vein
occlusion,
non-arteritic
ischaemic
optic
neuropathy,
glaucoma,
neurological
orbital
sequelae.
With
need
consider
telemedicine
consultation
view
COVID-19's
infectivity,
understanding
present
during
following
essential
ensure
appropriately
triaged,
prompt
in-person
examination
for
management
sight-threatening
life-threatening
diseases.
Language: Английский
Interdisziplinäre Therapie der Erkrankungen der Orbita
Anja Eckstein,
No information about this author
Hans‐Jürgen Welkoborsky
No information about this author
Laryngo-Rhino-Otologie,
Journal Year:
2024,
Volume and Issue:
103(S 01), P. S43 - S99
Published: May 1, 2024
Zusammenfassung
Die
Diagnostik
und
Therapie
von
Erkrankungen
der
Orbita
ist
eine
interdisziplinäre
Aufgabe,
an
u.a.
die
Fachdisziplinen
HNO-Heilkunde,
Augenheilkunde,
Radiologie,
Strahlentherapie,
MKG-Chirurgie,
Endokrinologie
Pädiatrie
beteiligt
sind.
Der
vorliegende
Übersichtsartikel
stellt
Zusammenstellung
häufigsten
dar,
mit
denen
HNO-Heilkunde
Augenheilkunde
interdisziplinär
befasst
Es
werden
akuten
entzündlichen
incl.
orbitaler
Komplikationen,
autoimmunologischen
endokrinen
Orbitopathie,
tumorösen
besprochen.
Neben
Beschreibung
Klinik
wird
besonderes
Augenmerk
auf
gelegt.
Abgerundet
wichtigsten
chirurgischen
Zugangswege
zur
Orbita,
ihre
Indikationen
mögliche
Komplikationen.
Autoren
haben
versucht,
trotz
knappen
Darstellung
relevanten
Fakten
zu
beschreiben.
Clinical Phenotypes of COVID-19 Associated Mucormycosis (CAM): A Comprehensive Review
Diagnostics,
Journal Year:
2022,
Volume and Issue:
12(12), P. 3092 - 3092
Published: Dec. 8, 2022
A
mucormycosis
surge
was
reported
during
the
COVID-19
pandemic
in
India.
literature
search
until
14
July
2022,
with
aim
of
updating
COVID-19-associated
(CAM),
identified
663
studies
and
88
met
inclusion
criteria
(8727
patients).
India
8388
patients,
Egypt
208
Europe
40.
Rhino-orbito-cerebral
(ROCM)
among
8082
(98.3%)
followed
by
98
(1.2%)
pulmonary.
In
India,
82.6%
patients
had
diabetes
mellitus,
82%
receiving
corticosteroids.
Europe,
75%
presented
pulmonary
CAM,
32.5%
40%
were
immunocompromised.
CAM
at
a
median
17.4
days
(IQR
7.5
days)
post
diagnosis,
PCR
performed
five
studies.
Rhino-orbital
invasion
is
clinically
obvious,
while
cerebral
involvement
presents
cavernous
sinus
thrombosis,
meningitis
cerebrovascular
disease.
Symptoms
usually
overlap
severe
pneumonia.
High-dose
liposomal
Amphotericin
B
(and
early
surgical
debridement
ROCM)
are
mainstay
therapy.
The
mortality
rate
estimated
to
be
21.4%
31.9%),
increased
presence
(80%
50%)
or
(50%
63.9%).
summary,
different
clinical
phenotypes
need
distinguished,
influenced
geographical
presentation.
Opportunities
exist
for
diagnosis
therapy
optimization,
based
on
earlier
high-dose
antifungal
therapy,
source
control,
strict
glycemic
control
restriction
steroids
oxygen
requirements.
Language: Английский
Review on Mucormycosis: Pathogenesis, Epidemiology, Microbiology and Diagnosis
Infectious Disorders - Drug Targets,
Journal Year:
2023,
Volume and Issue:
24(1)
Published: Aug. 23, 2023
Mucormycosis
is
a
serious
and
invasive
fungal
infection
caused
by
Mucorales
fungi.
This
review
article
provides
concise
overview
of
the
pathogenesis,
epidemiology,
microbiology,
diagnosis
mucormycosis.
The
introduction
section
highlights
key
microbiological
properties
pathogen
delves
into
underlying
mechanisms
mucormycosis
including
invasion
proliferation
fungus
within
host.
description
disease
focuses
on
epidemiology
mucormycosis,
its
incidence,
risk
factors,
geographical
distribution.
It
also
explores
specific
context
about
COVID-19
diabetes
mellitus,
highlighting
increased
susceptibility
observed
in
individuals
with
these
conditions.
A
case
study
illustrates
clinical
manifestations
challenges
associated
emphasizing
importance
early
detection.
Additionally,
discusses
significance
assessment,
radiological
imaging,
tests
for
accurate
timely
detection
infection.
Regarding
treatment,
covers
various
therapeutic
approaches,
antifungal
therapy,
surgical
interventions,
management
predisposing
limitations
treatment
options
are
addressed.
aims
to
provide
comprehensive
understanding
equipping
healthcare
professionals
valuable
insights
diagnostic
strategies.
By
enhancing
knowledge
awareness
this
infection,
can
improve
patient
outcomes
through
appropriate
management.
Language: Английский
Comparative Evaluation of COVID-19 Associated Mucormycosis (CAM) and Non-COVID-19-associated Mucormycosis (non-CAM)
Journal of College of Physicians And Surgeons Pakistan,
Journal Year:
2023,
Volume and Issue:
33(2), P. 153 - 157
Published: Feb. 1, 2023
Objective:
To
compare
COVID-19
associated
mucormycosis
cases
(CAM)
with
non-COVID-19
(non-CAM)
followed
as
in-patients.
Language: Английский
COVID-19 associated rhino-orbital-cerebral mucormycosis in patients with diabetes and comorbid conditions
Elsevier eBooks,
Journal Year:
2024,
Volume and Issue:
unknown, P. 473 - 483
Published: Jan. 1, 2024
Language: Английский
INCIDENCE OF RHINO-ORBITAL MUCORMYCOSIS IN PATIENTS WITH IMMUNOSUPPRESSION AFTER COVID-19
OTORHINOLARYNGOLOGY,
Journal Year:
2024,
Volume and Issue:
unknown, P. 14 - 22
Published: Jan. 1, 2024
Relevance:
Rhino-orbito-cerebral
mucormycosis
(ROCM)
is
a
fulminant
and
dangerous
disease
caused
by
invasive
fungi.
These
pathogens,
which
are
present
saprophytically
everywhere
in
the
environment,
can
get
caught
into
body
during
breathing.
Then
they
expand
mucosa
of
nasal
cavity
paranasal
sinuses,
after
that
-
spread
to
palate,
orbit
brain.
It
should
be
noted
rapidly
progressing
angioinvasive
infection.
Before
occurrence
COVID-19
pandemic,
this
pathology
was
endemic
mostly
found
countries
with
tropical
subtropical
climate.
However,
onset
second
wave
pandemic
appearance
COVID-associated
fungal
rhinosinusitis,
cases
have
unprecedented
increased
not
only
climates,
but
also
throughout
world.
Objective:
study
risk
factors
manifestations
patients
ROCM
prevent
find
possibility
early
diagnosis
treatment
pathology.
Materials
methods:
In
State
Institution
“O.S.
Kolomiychenko
Institute
Otolaryngology
National
Academy
Medical
Sciences
Ukraine”
2020-2023
we
examined
treated
6
signs
rhinosinusitis.
All
underwent
X-ray
examinations,
included
computed
tomography
(CT)
chest,
cavity,
sinuses.
Enhanced
magnetic
resonance
imaging
(MRI)
performed
orbital
or
intracranial
spreading
suspected.
Results
discussion:
According
anamnesis,
all
became
ill
Acute
rhinosinusitis
various
degrees
severity
began
observed
suffering
from
infection,
few
weeks
osteomyelitis
bones
skull
appeared
varying
damage
spreading.
4
out
had
diabetes
severity,
1
patient
HIV-infected
hepatitis
C,
diagnosed
cancer.
3
complicated
on
chronic
phlegmon
fistula
inner
corner
eye.
Destruction
endonasal
bone
structures
patients.
suffered
ptosis,
amaurosis
thrombosis
both
cavernous
sinuses
internal
carotid
arteries.
The
ethmoid
were
involved
pathological
process
cases,
maxillary
–
patients,
sphenoid
3,
frontal
2
cases.
surgical
treatment,
depended
degree
damage,
clinical
radiological
assessment
disease.
tissue
affected
areas
taken
for
histopathological
examination
Unfortunately,
there
no
pathognomonic
symptoms
mucormycosis,
it
may
nonspecific
occult
such
as
persistent
fever,
congestion,
facial
pain,
exophthalmos,
diplopia,
visual
loss,
altered
mental
status.
Numbness
skin
face
indicate
an
process.
Conclusion.
Rhino-orbital-cerebral
rare
There
significant
increase
its
frequency
pandemic.
We
didn`t
notice
rhino-orbital-cerebral
before
epidemic
Ukraine.
This
considered
due
infections
has
expanded,
kept
mind
absence
blackened
necrotic
scabs
diagnostic
endoscopy
does
exclude
mucormycosis.
A
high
index
suspicion
necessary
any
immunosuppressive
conditions,
especially
history
maxilla
and/or
base
prompt
doctor
immediately
re-examine
patient.
Key
words:
acute
invasion,
diabetes,
conditions.
Language: Английский
Degree of Orbital Affections in Cases of Nasal Mucormycosis Associated with COVID-19
Ezzeddin Mohamed El Sheikh,
No information about this author
Hani Mohamed Ali El Shamy,
No information about this author
Manar Muhammad Abdel Rehim
No information about this author
et al.
The Egyptian Journal of Hospital Medicine,
Journal Year:
2023,
Volume and Issue:
91(1), P. 4288 - 4293
Published: April 1, 2023
Background:
The
incidence
of
acute
invasive
fungal
sinusitis
(AIFS)
increased
without
obvious
cause
in
the
COVID-19
era
subsequently
there
is
a
burden
on
health
care
system.Objective:
In
our
study,
we
attend
to
find
best
assessment
for
orbital
affections
patients
with
AIFS
and
decrease
morbidity
rates.Therefore,
present
study
aimed
assess
functional
outcome
endoscopic
debridement
medical
treatment
cases
affection.Patients
methods:
A
one-arm
interventional
was
conducted
Orhinolaryngology,
Head
Neck
Surgery
Department,
Zagazig
University
Hospitals.The
included
19
patients,
aged
between
31
65
years,
who
had
symptoms
associated
nasal
mucormycosis
history
infection.Patients
have
undergone
surgery,
under
general
anesthesia.
Results:The
performed
intraoperatively
revealed
that
significant
percentage
septal
necrosis
(31.6%),
superior
turbinate
(10.5%)
inferior
(47.4%).Furthermore,
all
showed
middle
which
considered
be
classical
sign
by
examination.Regarding
prognosis
mortality,
most
(78.9%)
improvement
while
21.1%
died.
Conclusion:Early
combined
surgical
can
save
lives
salvage
eyes.
Language: Английский
Agents of Systemic and Subcutaneous Mucormycosis and Entomophthoromycosis
ClinMicroNow,
Journal Year:
2023,
Volume and Issue:
unknown, P. 1 - 23
Published: Aug. 11, 2023
Abstract
Mucormycosis
and
entomophthoromycosis
are
invasive
fungal
infections
caused
by
environmental
pauciseptate
filamentous
fungi.
Entomophthoromycosis
presents
as
subcutaneous
with
favorable
outcome
after
prolonged
azole
therapy
without
surgery,
although
it
is
potentially
associated
disfiguring
lesions.
can
develop
in
HIV‐infected
patients
intravenous‐drug
users.
The
diagnosis
of
mucormycosis
should
be
considered
an
emergency,
because
delaying
will
affect
outcome.
One
the
major
differences
between
that
former
occurs
mainly
predisposed
individuals,
whereas
latter
mostly
apparently
immunocompetent
hosts.
Culture
results
always
interpreted
light
clinical
presentation
along
direct
examination
and/or
histopathology.
Therapeutic
strategies
for
basidiobolomycosis
conidiobolomycosis
not
standardized
lack
trials
these
rare
infections.
Language: Английский
Agents of Systemic and Subcutaneous Mucormycosis and Entomophthoromycosis
ClinMicroNow,
Journal Year:
2023,
Volume and Issue:
unknown, P. 1 - 23
Published: Aug. 11, 2023
Abstract
Mucormycosis
and
entomophthoromycosis
are
invasive
fungal
infections
caused
by
environmental
pauciseptate
filamentous
fungi.
Entomophthoromycosis
presents
as
subcutaneous
with
favorable
outcome
after
prolonged
azole
therapy
without
surgery,
although
it
is
potentially
associated
disfiguring
lesions.
can
develop
in
HIV‐infected
patients
intravenous‐drug
users.
The
diagnosis
of
mucormycosis
should
be
considered
an
emergency,
because
delaying
will
affect
outcome.
One
the
major
differences
between
that
former
occurs
mainly
predisposed
individuals,
whereas
latter
mostly
apparently
immunocompetent
hosts.
Culture
results
always
interpreted
light
clinical
presentation
along
direct
examination
and/or
histopathology.
Therapeutic
strategies
for
basidiobolomycosis
conidiobolomycosis
not
standardized
lack
trials
these
rare
infections.
Language: Английский